Medicare Enrolled

Dr. Justin Holtzman, M.D.

Hospitalist Physician · Brookline, MA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1180 BEACON ST STE 6B, Brookline, MA 02446
7817704064
In practice since 2011 (15 years)
NPI: 1669769501 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Holtzman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Holtzman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Holtzman

Dr. Justin Holtzman is a hospitalist physician in Brookline, MA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Holtzman performed 1,026 Medicare services across 876 unique beneficiaries.

Between the years covered by Open Payments, Dr. Holtzman received a total of $9,866 from 37 pharmaceutical and/or device companies across 202 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hospitalist physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Holtzman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ Top 18% volume in MA $9,866 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,026
Medicare services
Top 18% in MA for hospitalist physician
876
Unique beneficiaries
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~68 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
COVID-19 vaccine administration
Administration of a single dose of the coronavirus vaccine.
178 $45 $60
COVID-19 vaccine (Moderna bivalent)
An intramuscular injection of the SARS-CoV-2 vaccine containing 50 micrograms in a 0.5 mL dose.
176 $142 $200
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
166 $98 $367
Adm sarscv2 bvl 50mcg/.5ml a 99 $45 $60
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
85 $94 $220
Remote patient monitoring management, 20 min/month
Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month.
58 $41 $75
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
52 $72 $249
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
33 $142 $460
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
29 $152 $491
Quadrivalent influenza vaccine, preservative-free
A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose.
25 $22 $60
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
24 $34 $90
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
20 $120 $553
Advance care planning consultation, first 30 min
A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion.
20 $86 $144
Annual depression screening 16 $21 $30
New patient office visit, complex (60-74 min) 15 $186 $693
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
15 $126 $316
Annual alcohol misuse screening, 5 to 15 minutes 15 $21 $30
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,866
Total received (2018-2024)
Avg $1,409/year across 7 years
Top 3% in MA for hospitalist physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
202
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,777 (58.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,088 (41.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$964
2023
$1,032
2022
$6,367
2021
$862
2020
$481
2019
$140
2018
$19

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$147
ABBVIE INC.
$121
Novartis Pharmaceuticals Corporation
$90
ViiV Healthcare Company
$86
PFIZER INC.
$78
Lilly USA, LLC
$53
Gilead Sciences, Inc.
$50
Madrigal Pharmaceuticals
$43
E.R. Squibb & Sons, L.L.C.
$40
Amgen Inc.
$38
UCB, Inc.
$28
Organon Llc
$22
Regeneron Healthcare Solutions, Inc.
$21
ANI Pharmaceuticals, Inc.
$21
Esperion Therapeutics, Inc.
$19
Novo Nordisk Inc
$19
Janssen Pharmaceuticals, Inc
$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18
SHIELD THERAPEUTICS INC
$18
Celgene Corporation
$17
Janssen Biotech, Inc.
$16
Top 3 companies account for 37.1% of 2024 payments
All-time payments by company (2018-2024) ›
Biohaven Pharmaceutical Holding Company Ltd.
$5,337
ABBVIE INC.
$710
Ortho Dermatologics, a division of Bausch Health US, LLC
$440
Gilead Sciences, Inc.
$353
Janssen Pharmaceuticals, Inc
$332
PFIZER INC.
$288
MERZ NORTH AMERICA, INC.
$229
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$205
GENZYME CORPORATION
$165
Lilly USA, LLC
$161
Biohaven Pharmaceuticals, Inc.
$160
Novartis Pharmaceuticals Corporation
$150
ViiV Healthcare Company
$148
AbbVie Inc.
$138
Amgen Inc.
$132
Galderma Laboratories, L.P.
$119
Celgene Corporation
$117
RedHill Biopharma Inc.
$84
IDORSIA PHARMACEUTICALS US INC
$71
Novo Nordisk Inc
$49
Madrigal Pharmaceuticals
$43
E.R. Squibb & Sons, L.L.C.
$40
IMPEL PHARMACEUTICALS INC.
$37
AstraZeneca Pharmaceuticals LP
$36
Hologic Sales and Service, LLC
$35
Janssen Biotech, Inc.
$35
Teva Pharmaceuticals USA, Inc.
$34
UCB, Inc.
$28
VBI Vaccine (Delaware) Inc.
$27
Organon Llc
$22
Takeda Pharmaceuticals U.S.A., Inc.
$22
Regeneron Healthcare Solutions, Inc.
$21
ANI Pharmaceuticals, Inc.
$21
Otsuka America Pharmaceutical, Inc.
$19
Esperion Therapeutics, Inc.
$19
Exeltis, USA Inc.
$18
SHIELD THERAPEUTICS INC
$18
Top 3 companies account for 65.8% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AMJEVITA · APRETUDE · APTIMA · AUSTEDO · Aimovig · CABLIVI · COMIRNATY · CREON · Cimzia · DUPIXENT · Descovy · EMGALITY · ENTRESTO · Enbrel · FARXIGA · HADLIMA · LEQVIO · LINZESS · MOUNJARO · NEXLETOL · NURTEC ODT · ORENCIA · Ozempic · PAXLOVID · PREVNAR 20 · PURIFIED CORTROPHIN GEL · PreHevbrio · QULIPTA · QUVIVIQ · RESMETIROM · REXULTI · Rybelsus · SALEX · SLYND · STELARA · THINPREP 2000 PROCESSOR · TRULANCE · TRULICITY · Talicia · Trudhesa · UBRELVY · VIBERZI · VYVANSE · Wegovy · XARELTO · XELJANZ · XIFAXAN · ZEPBOUND · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (59%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hospitalist physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for hospitalist physician in MA.

Looking for a hospitalist physician in Brookline?
Compare hospitalist physicians in the Brookline area by procedure volume, costs, and industry payment transparency.
Browse hospitalist physicians nearby

Geographic Context

Hospitalist physicians within 10 mi
249
Per 100K population
34.4
County median income
$126,497
Nearest hospital
ARBOUR HUMAN RESOURCE INSTITUTE
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Holtzman is a clinical cardiology specialist, with above-average Medicare volume (top 18% in MA), with speaking/promotional industry engagement in the top 3% of MA peers, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Holtzman experienced with covid-19 vaccine administration?
Based on Medicare claims data, Dr. Holtzman performed 178 covid-19 vaccine administration services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Holtzman receive payments from pharmaceutical companies?
Yes. Dr. Holtzman received a total of $9,866 from 37 companies across 202 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Holtzman's costs compare to other hospitalist physicians in Brookline?
Dr. Holtzman's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Holtzman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →